Clinical Trial Update: Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical study to evaluate the safety, pharmacokinetics, and efficacy of VC005 in adolescents with mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• VC005

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: COMPLETED